• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 National Evidence-based Healthcare Collaborating Agency (NECA) [Outcomes research of preventive procedures in unruptured intracranial aneurysm]
2011 National Evidence-based Healthcare Collaborating Agency (NECA) [Research on methodologies for evidence-based healthcare decision-making processes in Korea]
2011 Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: prostate cancer screening using MRI
2011 Health Council of the Netherlands Gezondheidsraad (GR) On the role of vaccination in preparation for an influenza pandemic
2011 Institute for Clinical Evaluative Sciences (ICES) Geographic access to primary care and hospital services for rural and northern communities: report to the Ontario Ministry of Health and Long-Term Care
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Criteria for assessment of the effect of preventive interventions]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Effect of vitamins, minerals and other dietary supplements on mental health symptoms for people with ADHD, anxiety disorders, bipolar disorder or depression]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) Effect of vitamins, fatty acids, minerals, and other dietary supplements on schizophrenic symptoms in people with schizophrenia
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [The effects of group education on patients and their next of kin]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Intermediate care units and hospital at home for acute exacerbations of COPD]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Motivational interviewing for HIV-related behaviors among men who have sex with men]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Effect of patient hotels for hospitals and patients]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Triage systems for emergency medical services – pre-hospital and at hospital admission]
2011 University of York Supporting women with postnatal depression through psychological therapies
2011 University of York Evidence briefing on specialist nurses in acute hospital settings
2011 University of York Evidence briefing on nurse endoscopy
2011 University of York Evidence briefing on integrated care pathways in mental health settings
2011 Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in esophageal cancer
2011 Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in colorectal cancer
2011 Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) In vitro test for the evaluation of individual risk of metastasis in surgically treated women for breast cancer
2011 Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in breast cancer
2011 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personal]
2011 Medical Services Advisory Committee (MSAC) Use of artificial disc replacement in patients with cervical degenerative disc disease
2011 Medical Services Advisory Committee (MSAC) Assessment of application for joint injections
2011 Medical Services Advisory Committee (MSAC) Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011 Medical Services Advisory Committee (MSAC) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1
2011 Institute for Clinical and Economic Review (ICER) Management options for low back disorders
2011 HTA Unit, University of Calgary Health technology reassessment and reinvestment: a systematic review of current practices
2011 Haute Autorite de sante (HAS) [Transcutaneous aortic valve implantation by the transfemoral or transapical route]
2011 Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [Albumin (or protein) to creatinine ratios in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [MRI-guided vacuum-assisted breast biopsy (VABB)]
2011 Haute Autorite de sante (HAS) [Surgical haemostatic agents: treatments of last resort]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: bleeding time]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: thrombin time]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: photometric platelet aggregation test]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: testing for antibodies to platelet factor 4 in a patient with heparin – induced thrombocytopenia]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: detection and titration of antihaemophilic factor (AHF) inhibitor]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: lupus anticoagulant detection]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: testing for the G1691A mutation of the factor V gene (Leiden FV) and the G20210A mutation of the factor II gene]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis abnormalities – summary]
2011 Haute Autorite de sante (HAS) [Selection of iron metabolism tests in cases where iron deficiency is suspected]
2011 Haute Autorite de sante (HAS) [Self-monitoring of blood glucose in type 2 diabetes: limited use for a target population]
2011 Haute Autorite de sante (HAS) [Dressings: indications and recommended uses]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Genetics development plan in the Basque Country]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Financing procedures in primary care adequate for resources and efficiency, by means of adjusted clinical groups (ACG)]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Case and control study: efficiency of psychoeducational treatment of the overload experienced by family members of bipolar patients]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2011 Basque Office for Health Technology Assessment (OSTEBA) [The development of the set of basic data on specialised ambulatory care (SBD-SAC) of Osakidetza. Pilot scheme in three hospitals]
2011 Adelaide Health Technology Assessment (AHTA) Technologies for the inactivation/reduction of pathogens in blood products
2011 Finnish Office for Health Care Technology Assessment (Finohta) [Azacitidine in the treatment of high-risk myelodysplastic syndrome]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bupropion, mirtazapine, and reboxetine in the treatment of depression]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report v. 1.1)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dipyridamole and aspirin for secondary prevention after stroke or TIA]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in head and neck tumours]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [What type of evidence is currently being considered in the development of clinical practice guidelines for rare diseases? - rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Responder analyses for memantine in Alzheimer's disease - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Search for literature on angiotensin II antagonists and ACE inhibitors]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in malignant melanoma]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of long-term blood glucose lowering to normal levels in patients with diabetes mellitus type 2 - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP diabetes mellitus type 1 and extraction of new, relevant recommendations]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Prasugrel in the treatment of acute coronary syndrome]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ezetimibe for hypercholesterolaemia]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reduction of alcohol consumption in essential hypertension - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reduction of alcohol consumption in essential hypertension - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of non-drug treatment strategies in patients with essential hypertension: Special diets without the primary aim of reducing weight or salt intake - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Stem cell transplantation for multiple myeloma]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of non-drug treatment strategies in patients with diabetes mellitus type 2: increase of physical activity - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cessation of smoking in essential hypertension - Rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP diabetes mellitus type 2 and extraction of new, relevant recommendations]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fact sheet: Screening for gestational diabetes - rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to the final report A09-02 (benefit assessment of prasugrel)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of HPV test in primary screening for cervical cancer]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Boceprevir - Benefit assessment according to 35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pirfenidone - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP module on heart failure and extraction of new, relevant recommendations]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Stem cell transplantation for multiple myeloma: assessment of the BMT CTN 0102 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Linagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Abiraterone acetate - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2011 National Institute for Health and Care Excellence (NICE) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. NICE technology appraisal guidance 223
2011 National Institute for Health and Care Excellence (NICE) Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs. NICE technology appraisal guidance 225
2011 National Institute for Health and Care Excellence (NICE) Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma. NICE technology appraisal guidance 226
2011 National Institute for Health and Care Excellence (NICE) Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer. NICE technology appraisal guidance 227
2011 National Institute for Health and Care Excellence (NICE) Bortezomib and thalidomide for the first-line treatment of multiple myeloma. NICE technology appraisal guidance 228
2011 National Institute for Health and Care Excellence (NICE) Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 229
2011 National Institute for Health and Care Excellence (NICE) Agomelatine for the treatment of major depressive episodes (terminated appraisal). NICE technology appraisal guidance 231
2011 National Institute for Health and Care Excellence (NICE) Mifamurtide for the treatment of osteosarcoma. NICE technology appraisal guidance 235
2011 National Institute for Health and Care Excellence (NICE) Ticagrelor for the treatment of acute coronary syndromes. NICE technology appraisal guidance 236
2011 National Institute for Health and Care Excellence (NICE) Tocilizumab for the treatment of systemic juvenile idiopathic arthritis. NICE technology appraisal guidance 238
2011 National Institute for Health and Care Excellence (NICE) Fulvestrant for the treatment of locally advanced or metastatic breast cancer. NICE technology appraisal guidance 239
2011 National Institute for Health and Care Excellence (NICE) Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal). NICE technology appraisal guidance 240
2011 National Institute for Health and Care Excellence (NICE) Epiretinal brachytherapy for wet age-related macular degeneration. NICE interventional procedures guidance 415
2011 National Institute for Health and Care Excellence (NICE) Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants. NICE interventional procedures guidance 412
2011 National Institute for Health and Care Excellence (NICE) Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. NICE interventional procedures guidance 413
2011 National Institute for Health and Care Excellence (NICE) Single-port laparoscopic nephrectomy. NICE interventional procedures guidance 414
2011 National Institute for Health and Care Excellence (NICE) Arthroscopic femoro–acetabular surgery for hip impingement syndrome. NICE interventional procedures guidance 408
2011 National Institute for Health and Care Excellence (NICE) Minimally invasive oesophagectomy. NICE interventional procedures guidance 407